newsfilter
← Latest News
GlobeNewswire·

Orgenesis Announces Expanded Partnership Between Octomera and UC Davis Through CIRM Grant Funding

GERMANTOWN, Md., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ:ORGS) ("Orgenesis" or the "Company"), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today